Nachrichten zur Johnson & Johnson Aktie

Johnson Controls raised to Buy at BofA on data center exposure, forthcoming CEO

…

12:28: Die meistgehandelten Produkte: Johnson & Johnson bietet Vergleich an!

Nach einer turbulenten Handelswoche zeigt der DAX® am Montag eine leichte Erholung, wobei er wieder über seine wichtigen 50- und…

Global Hematologic Malignancies Market Size To Worth USD 144.58 Billion By 2033 | CAGR Of 7.97%

The Global Hematologic Malignancies Market Size was Valued at USD 67.18 Billion in 2023 and the Worldwide Hematologic Malignancies Market…

2 Dividend Stocks With Payouts That May Not Be as Safe as They Seem @themotleyfool #stocks $JNJ $MO $INTC $WBA

Johnson & Johnson and Altria Group are two prominent dividend stocks, but I wouldnt rely on their payouts.…

Johnson & Johnson wins over longtime holdout for talc settlement, WSJ reports By Reuters

Johnson & Johnson wins over longtime holdout for talc settlement, WSJ reports…

Johnson & Johnson (JNJ) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)

…

Global Burn Care Market Size To Worth USD 4.88 Billion By 2033 | CAGR Of 7.3%

The Global Burn Care Market Size was Valued at USD 2.41 Billion in 2023 and the Worldwide Burn Care Market…

Nestlé-Werk Biessenhofen investiert Millionenbetrag in neue Wärmepumpe und reduziert CO2

Frankfurt am Main (ots) - Nestlé spart im Werk Biessenhofen bei der Produktion von Säuglingsnahrung Energie und CO2 ein. Das…

Nestlé-Werk Biessenhofen investiert Millionenbetrag in neue Wärmepumpe und reduziert CO2

Nestlé Deutschland AG: Frankfurt am Main (ots) - Nestlé spart im Werk Biessenhofen bei der Produktion von Säuglingsnahrung Energie und…

Is Johnson & Johnson the Best Dividend Stock for You?

You wont find a more dependable dividend payer on Wall Street. But whether its the best stock for you depends…

Is Johnson & Johnson the Best Dividend Stock for You?

…

JNJ Seeks First FDA Nod for Autoimmune Disease Drug Nipocalimab

The Johnson & Johnson filing seeks the FDAs approval for nipocalimab to treat generalized myasthenia gravis in a broad population…

Johnson Controls: Strategic Flywheel Gaining Momentum

…

Is Johnson & Johnson Stock a Buy?

The company hasnt performed well in recent years,…

Johnson & Johnson: The Dividend King Is Back

…

Nerdys (NRDY) VTS Partners With Johnson County Schools

Nerdys (NRDY) leading tutoring services provider partners with Johnson County Schools to offer free access to the VTS platform to…

J&J (JNJ) to Boost MedTech Business With V-Wave Acquisition

Johnson & Johnson (JNJ) inks a definitive agreement to acquire V-Wave Ltd. for an upfront payment of $600 million. The…

Johnson & Johnson to acquire V-Wave in deal worth up to $1.1bn By Investing.com

Johnson & Johnson to acquire V-Wave in deal worth up to $1.1bn…

Johnson & Johnson gets green light for lung cancer combination treatment By Investing.com

Johnson & Johnson gets green light for lung cancer combination treatment…

HistoSonics: Überzeichnete Serie D-Finanzierung von $102 Millionen zur Markteinführung von nicht-invasiver Histotripsie-Plattform

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, Hersteller des Edison ® Histotripsie-Systems und neuer Histotripsie-Therapie-Plattformen, hat heute die Beendigung einer überzeichneten Serie-D-Finanzierung von $102 Millionen…

Goldman belässt Astrazeneca auf Buy - Ziel 15756 Pence

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca nach veröffentlichten Fachartikeln für die anstehende…

Analyst Report: Johnson Controls Intl pl

…

J&Js (JNJ) DePuy Synthes TriLEAP System to Aid Ankle Surgery

Johnson & Johnsons (JNJ) DePuy Synthes announces the launch of its TriLEAP System, which is likely to provide better orthopedic…

Johnson Outdoors Inc. (JOUT) Q3 2024 Earnings Call Transcript

…

Johnson Outdoors Reports Fiscal Third Quarter Results

RACINE, Wis., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq:JOUT), a leading global innovator of outdoor…

The Markets Excessive Recession Fears

We comment on the ongoing market sell-off, in addition to featuring new research reports on Johnson & Johnson (JNJ), T-Mobile…

Invest $50K in Johnson & Johnson to Become a Dividend Millionaire in 10 Years

…

Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now

These two healthcare companies have far more upside potential than Johnson & Johnson.…

Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now @themotleyfool #stocks $VRTX $JNJ $ISRG

These two healthcare companies have far more upside potential than Johnson & Johnson.…

Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for Growth

Abbott Laboratories growth rate may look comparable to Johnson & Johnsons, but in the long run it could become much…

Führungswechsel bei Johnson & Johnson: Urs Vögeli ist neuer Managing Director

Janssen-Cilag GmbH: Neuss (ots) - Urs Vögeli ist seit dem 1. August 2024 Vorsitzender der Geschäftsführung der Janssen-Cilag GmbH, dem…

United States Pain Management Therapeutics Market Research 2024-2032 Featuring Eli Lilly and Co, Pfizer,. GSK,c Novartis, Merck & Co, Abbott Laboratories, Johnson & Johnson, & Baxter

Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "United States Pain Management Therapeutics Market and Forecast Therapeutics (Devices…

dpa-AFX ProFeed